|
Uveitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Efficacy trended better with EGP-437 among patients with more severe baseline uveitis (AC cell count >25).
|
31726034 |
2020 |
|
Congenital contractural arachnodactyly
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CD133 or EpCAM expression in the CCA component was associated with poor prognosis in cHCC-CCA.
|
31661725 |
2020 |
|
Intermediate cell carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
For EpCAM, the positive rate in the CCA component (71.4%) and INT component (50.0%) tended to be higher than the HCC component (14.3%) in cHCC-CCA.
|
31661725 |
2020 |
|
Atrial Fibrillation
|
0.010 |
Biomarker
|
disease |
BEFREE |
These were validated offline in their ability to identify the ESA targeted with a study-defined ablation response (AF termination or cycle length [CL] slowing of ≥30 ms).
|
31552697 |
2019 |
|
Flushing
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
After covalent attachment of anti-EpCAM (epithelial cell adhesion molecule) antibodies on stainless steel substrates, EV samples derived from a prostate cancer cell line (LnCAP) were flushed into a microfluidic device assembled with this stainless steel substrate for capture.
|
31292600 |
2019 |
|
Hematological Disease
|
0.010 |
Biomarker
|
group |
BEFREE |
Thalassemia (Thal) is an inherited blood disorder endemic to the Mediterranean and Middle East (e.g., KSA and UAE).
|
31141729 |
2019 |
|
Hepatitis, Alcoholic
|
0.010 |
Biomarker
|
disease |
BEFREE |
EPCAM was predicted to regulate AH progression through the PI3K/Akt/mTOR signaling pathway.
|
31378124 |
2019 |
|
Liver diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
LGR5 is predominant in peri-septal hepatocytes rather than epithelial cell adhesion molecule (EpCAM) positive ductular reactions in chronic pediatric liver diseases and may represent a transitional HPC phenotype for the hepatocyte lineage.
|
28276299 |
2019 |
|
Lymphatic Metastasis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Prognostic value of biomarkers EpCAM and αB-crystallin associated with lymphatic metastasis in breast cancer by iTRAQ analysis.
|
31443698 |
2019 |
|
Mesothelioma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Immunocytochemical studies on PF cell blocks allow: (a) to distinguish mesothelioma from reactive mesothelial proliferations (e.g. loss of BAP1 nuclear expression, complemented by the demonstration of p16 deletion using fluorescence in situ hybridization, indicate mesothelioma); (b) to separate mesothelioma from adenocarcinoma (e.g. calretinin, CK 5/6, WT-1 and D2-40 are markers of mesothelioma, whereas CEA, EPCAM, TTF-1, napsin A, and claudin 4 are markers of carcinoma); and (c) to reveal tumor origin in pleural metastases of an unknown primary site (e.g.
|
30354850 |
2019 |
|
Pleural effusion disorder
|
0.010 |
Biomarker
|
group |
BEFREE |
EpCAM(cl) is a new biomarker of adenocarcinomatous PE with meaningful discriminating properties.
|
30903651 |
2019 |
|
Thalassemia
|
0.010 |
Biomarker
|
group |
BEFREE |
Thalassemia (Thal) is an inherited blood disorder endemic to the Mediterranean and Middle East (e.g., KSA and UAE).
|
31141729 |
2019 |
|
Secondary malignant neoplasm of bone
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
No correlation of EpCAM overexpression with pT stage and lymph node metastasis was observed; however, EpCAM overexpression showed a significant correlation with Gleason score (OR = 0.48, P = 0.012) and bone metastasis (OR = 145.80, P < 0.001).
|
31324239 |
2019 |
|
Hereditary pancreatitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
LGR5 is predominant in peri-septal hepatocytes rather than epithelial cell adhesion molecule (EpCAM) positive ductular reactions in chronic pediatric liver diseases and may represent a transitional HPC phenotype for the hepatocyte lineage.
|
28276299 |
2019 |
|
Fibrosis, Liver
|
0.010 |
Biomarker
|
disease |
BEFREE |
Silencing EPCAM or inhibition of the PI3K/Akt/mTOR signaling pathway inhibited the hepatic fibrosis and HSC proliferation yet induced HSC apoptosis.
|
31378124 |
2019 |
|
Adenocarcinoma of colon
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Seven cancerous tissue samples of colon adenocarcinoma and corresponding noncancerous tissue samples were sorted by fluorescence-activated cell sorting using epithelial cell adhesion molecule as a marker for epithelial cells.
|
30918593 |
2019 |
|
Infection caused by Helicobacter pylori
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
From the literature review, there seem to be no studies conducted on infection caused by Helicobacter pylori in patients with gastric MALT lymphoma in the KSA region.
|
31250359 |
2019 |
|
Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
From the literature review, there seem to be no studies conducted on infection caused by Helicobacter pylori in patients with gastric MALT lymphoma in the KSA region.
|
31250359 |
2019 |
|
HER-2 positive breast cancer
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In addition, the expression levels of ALDH1A3, ALDH3B2 and EpCAM were higher in HER‑2‑positive breast cancer compared with in paracancerous tissues and other subtypes of breast cancer, as determined by immunohistochemistry.
|
31545416 |
2019 |
|
MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA
|
0.010 |
Biomarker
|
disease |
BEFREE |
We aimed to demonstrate the feasibility of non-invasive enumeration and immunophenotyping of EpCAM-positive cells in pleural fluid samples for the diagnosis of a MPE in NSCLC patients.
|
30642547 |
2019 |
|
Metastatic castration-resistant prostate cancer
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our results reveal for the first time a remarkable heterogeneity in the expression levels of AR-FL, AR-V7 and AR-567es in EpCAM+ CTCs and paired extracellular vesicles between individual mCRPC patients.
|
31596277 |
2019 |
|
Biliary Atresia
|
0.010 |
Biomarker
|
disease |
BEFREE |
The expression of CK19, Sox9, and EpCAM was significantly increased in BA liver, while DAPT treatment decreased the expression of CK19, Sox9, and EpCAM.
|
30196281 |
2018 |
|
Adenoid Cystic Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Expression of EpCAM in adenoid cystic carcinoma.
|
30389218 |
2018 |
|
Kidney Failure, Chronic
|
0.010 |
Biomarker
|
disease |
BEFREE |
Personalized Anemia Management and Precision Medicine in ESA and Iron Pharmacology in End-Stage Kidney Disease.
|
30082060 |
2018 |
|
Liver Cirrhosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Progenitor-derived regeneration depicted by K7 and EpCAM immunostaining of hepatocytes in liver biopsies of patients with compensated HCV-related cirrhosis marks a cirrhosis stage more prone to develop complications.(HEPATOLOGY 2018; 68:1534-1548).
|
29637581 |
2018 |